Gordon Haskett’s head of event-driven research Don Bilson contends that "the world may have been a little too quick to buy into the idea" that Danaher (DHR) has lost interest in Catalent (CTLT) after Bloomberg reported on April 17 that the former had stopped pursuing the latter. While "strictly speaking, that may be the case as talks could have been shelved," that doesn’t mean they won’t be rekindled, according to the firm, which adds that it "certainly didn’t hear anything from DHR yesterday that has us thinking this story is over." In fact, the firm’s takeaway from the M&A comments Danaher made on its Q1 call yesterday has Gordon Haskett thinking "quite the opposite," as it believes there was a disagreement over price and Catalent "could still come around."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTLT:
- Catalent price target lowered to $49 from $78 at BofA
- Catalent (NYSE:CTLT) Is Not on Danaher’s (NYSE:DHR) Buy List
- Catalent price target lowered to $40 from $70 at Barclays
- Danaher shelves pursuit of Catalent deal, Bloomberg reports
- Catalent down 6% after Bloomberg says Danaher shelves takeover pursuit
